Uterine Corpus Leiomyoma clinical trials
23 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Prescription of Letrozole for Uterine Myoma
- Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
- Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy
- The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.
- An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
- Assessment of Tubal Occlusion During Minimally Invasive Myomectomy
- Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
- Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
- Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
- Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
- Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
- Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
- Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- Videos to Aid Decision Making for Fibroid Treatment
- QL Block in Laparoscopic Myomectomy
- Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief
- Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
- Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
- COVID-19 Experiences in the SELF Cohort
- Quest to Analyze One Thousand Humans Meditating
- Effects of Simvastatin on Uterine Leiomyoma Size
- Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Uterine Corpus Leiomyoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.